Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

NCT01139138 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colorectal Carcinoma
Colorectal Tumors
Neoplasms, Colorectal

Interventions

DRUG: Panitumumab
DRUG: Irinotecan
DRUG: Everolimus

Sponsor

The Queen Elizabeth Hospital

Collaborators

[object Object]
[object Object]